News & Insights

In the News

February 10, 2022 - Source: Pink Sheet

Preeya Pinto explains why the Centers for Medicare and Medicaid Services diverged from its statutory authority and past precedents when it proposed that Medicare would only cover Alzheimer’s drugs when patients are enrolled in an approved randomized clinical trial

Go to the article